About
ACell, Inc. is a biotechnology company founded in 1999 and based in Columbia, Maryland. The company specializes in regenerative medicine, focusing on the development and commercialization of extracellular matrix (ECM) products derived from porcine urinary bladder tissue. Their core technology, MatriStem UBM™, creates scaffolds that support tissue regeneration and remodeling, leveraging the body's natural healing processes. ACell offers a variety of products for medical and veterinary applications, including wound management solutions like Cytal and MicroMatrix, hernia repair products such as Gentrix, and pelvic organ prolapse repair with the Pelvic Floor Matrix. Their ECM products are available in both sheet and powder forms, catering to different clinical needs. ACell's technology has garnered significant research interest, with over 100 published scientific papers highlighting its applications in surgery, wound care, and veterinary medicine. In January 2021, ACell was acquired by Integra LifeSciences, enhancing their offerings in complex wound care and surgical reconstruction.
Technologies
Keywords
Company Information
-
Employees 100
-
Founded 2002
-
Annual Revenue $1621738000
Location
6640 Eli Whitney Drive, Columbia, Maryland, United States, 21046